Our ongoing research within APTG resulted in establishing a network of worldwide contacts with multiple leading institutions in particle therapy. Noteworthy are the formalized collaborations between APTG and the German Cancer Research Center (DKFZ), Germany, Heidelberg Ion-Beam Therapy Center (HIT), Germany, and Institute for Nuclear Research of the Russian Academy of Sciences, Russia.

 

Formalized collaborations:

• Deutsches Krebsforschungszentrum, Heidelberg (DKFZ), Research Group Heavy Ion Therapy (E409)
• UniKlinikum Heidelberg, Heidelberg Ion-Beam Therapy Center (HIT)
• Institute for Nuclear Research of the Russian Academy of Sciences - SHIELD-HIT12A Monte Carlo code development, joint ownership.
• Gesellschaft für Schwerionenforschung (GSI), Darmstadt, Germany - Treatment planning with heavy ions.

Informal collaborators:

• National Physical Laboratory (NPL), Teddington, UK. - Dosimetry and alanine solid state detectors
• Oslo University Hospital, Norway. - Lithium formate dosimetry in hadron beams.
• Department of Physics, University of New Mexico, Albuquerque - Antiproton therapy research, treatment planning system software development.
• The Henryk Niewodniczańsski Institute of Nuclear Physics - Polish Academy of Sciences, IFJ-PAN, Development of radiation detectors and the Monte Carlo code SHIELD-HIT12A.

Back to APTG main page